Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (451-460 of 548) with videos related to

Pageof 55
Sort By:
Psychopharmacology|January 1, 1992
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosetsP A Löschmann, L A Smith, K W Lange, et al.
Lancet (London, England)|June 22, 1985
Benztropine inhibits toxicity of MPTP in miceA J Bradbury, M E Kelly, B Costall, et al.
The European Journal of Neuroscience|July 7, 2007
Striatal leucine-rich repeat kinase 2 mRNA is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned common marmosets (Callithrix jacchus) with L-3, 4-dihydroxyphenylalanine methyl ester-induced dyskinesiaM J Hurley, P H Patel, M J Jackson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Mitochondrial DNA analysis in Parkinson's diseaseA H Schapira, I J Holt, M Sweeney, et al.
Biochemical Pharmacology|August 1, 1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the ratN M Rupniak, M D Hall, S Mann, et al.
European Journal of Pharmacology|January 12, 1993
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsS Rose, M Nomoto, E A Jackson, et al.
Free Radical Research|February 1, 1996
Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's diseaseJ P Spencer, A Jenner, J Butler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Iron in the Parkinsonian substantia nigraM Gerlach, K Double, P Riederer, et al.
Psychopharmacology|February 1, 1995
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmosetK K Gnanalingham, D D Erol, A J Hunter, et al.
Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.
Pageof 55

Showing results (451-460 of 548) with videos related to

Sort By:
Pageof 55
Psychopharmacology|January 1, 1992
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosetsP A Löschmann, L A Smith, K W Lange, et al.
Lancet (London, England)|June 22, 1985
Benztropine inhibits toxicity of MPTP in miceA J Bradbury, M E Kelly, B Costall, et al.
The European Journal of Neuroscience|July 7, 2007
Striatal leucine-rich repeat kinase 2 mRNA is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned common marmosets (Callithrix jacchus) with L-3, 4-dihydroxyphenylalanine methyl ester-induced dyskinesiaM J Hurley, P H Patel, M J Jackson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
Mitochondrial DNA analysis in Parkinson's diseaseA H Schapira, I J Holt, M Sweeney, et al.
Biochemical Pharmacology|August 1, 1985
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the ratN M Rupniak, M D Hall, S Mann, et al.
European Journal of Pharmacology|January 12, 1993
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosetsS Rose, M Nomoto, E A Jackson, et al.
Free Radical Research|February 1, 1996
Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's diseaseJ P Spencer, A Jenner, J Butler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Iron in the Parkinsonian substantia nigraM Gerlach, K Double, P Riederer, et al.
Psychopharmacology|February 1, 1995
Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmosetK K Gnanalingham, D D Erol, A J Hunter, et al.
Psychopharmacology|January 1, 1984
Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the ratN M Rupniak, S Mann, M D Hall, et al.
Pageof 55